Hyphens Pharma Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, launched its Ceradan® Advanced Hand Balm, the latest addition to its Ceradan® line for […]
Tag: Hyphens Pharma
Hyphens Pharma 1H2024 net profit jumps 66.7% to S$5.9 million
Hyphens Pharma Limited reported 1H2024 revenue grew by 33.4% to S$99.6 million in 1H2023 with all three business segments contributing to the growth. Revenue from […]
Hyphens Pharma to bring relief to Shingles sufferers in ASEAN with licensing of Amenalief®
Singapore’s leading specialty pharmaceutical and consumer healthcare group, Hyphens Pharma International Limited’s subsidiary, Hyphens Pharma Pte. Ltd., has entered into an exclusive license, development and […]
Hyphens Pharma 3Q2023 net profit drops to S$4 million due to challenging macro environment and record 3Q2022 results
Hyphens Pharma Limited has released its quarterly business update for 3Q2023 and 9M2023. 3Q2023 compared to 3Q2022 Revenue in 3Q2023 remained constant at S$42.8 million […]
Hyphens Pharma acquires Ardence Pharma in Malaysia
Hyphens Pharma Limited has acquired Ardence Pharma Sdn Bhd, a boutique pharmaceutical company specializing in aesthetic medicine and an existing associate company of Hyphens Group […]
Hyphens Pharma to develop and commercialise Byfavo® anaesthetic drug with Hana Pharm in Singapore
Hyphens Pharma Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, has signed an exclusive sub-license and supply agreement with Hana Pharm Co., Ltd. to […]
Hyphens Pharma sees soft 1Q2023 due to end of Biosensors distributorship and Vietnam shipment delays
1Q2023 Financial Review Hyphens Pharma Limited’s revenue fell by 15.2% or S$6.0 million from S$39.2 million in 1Q2022 to S$33.2 million in 1Q2023. This was […]
Hyphens Pharma successfully registers botox formulation Nabota® in Singapore
Hyphens Pharma International Limited has successfully registered the botulinum toxin formulation Nabota® from Daewoong Pharmaceutical Co., Ltd. (Daewoong Pharmaceutical) in Singapore on 20 January 2023. […]
Cosmo Pharmaceuticals’ Winlevi® coming to ASEAN as part of exclusive Hyphens Pharma license agreement
Hyphens Pharma International Limited has entered into exclusive license and supply agreements with Cassiopea S.p.A., (Cosmo Pharmaceuticals) for the exclusive rights to develop and commercialize […]